Since SFN combined with TRAIL upregulated ROS generation and reduced Nrf2, these investigators hypothesized that SFN sensitizes the tumor cells to TRAIL-mediated apoptosis by generating ROS that overcomes an Nrf2-mediated defense system established in resistant cells [71]. The gene discussed is TNFSF10; the disease is neoplasm.